English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
University of California Irvine Medical Center
ESMO 33
12 - 16 Sep 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Dec 2008
Views:
15078
Rating:
Save
Rate video
Prof. Bradley Monk
Promising new treatment option for women with recurrent ovarian cancer.
Categories:
Ovary & gynaecology
Related Videos
Addressing women’s cancers: an economic evaluation of breast and cervical cancer...
Dr Mary Nyangasi - Head of the National Cancer Control Programme, Nairobi, Kenya
23 Nov 2022
Assessment of cervical and breast cancer screening in Latin America and Caribbea...
Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France
21 Nov 2022
My top "ten" choosing wisely for India gynaecological malignancies
Dr Shona Nag - Sahyadri group of hospitals, Pune, India
26 Oct 2022
Intraoperative Radiotherapy
Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal
25 Sep 2022
Atezolizumab added to chemo fails to improve PFS in relapsed ovarian cancer
Prof Jean Emmanuel Kurtz - Strasbourg Cancer Institute, Strasbourg, France
10 Sep 2022
Cervical cancer programme in Kenya: lessons to guide elimination as a public hea...
Dr Valerian Mwenda - Ministry of Health, Nairobi, Kenya
25 Aug 2022
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and...
Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey
30 Jun 2022
Rucaparib effective as maintenance therapy following first-line platinum-based c...
Dr Bradley Monk - University of Arizona College, Tucson, USA
21 Jun 2022
More from
e
cancer